| Elizabeth C Roy, DPT | |
|
3 Federal Rd Ste 100, Brookfield, CT 06804 | |
| (203) 456-1010 | |
| (203) 456-1011 |
| Full Name | Elizabeth C Roy |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 7 Years |
| Location | 3 Federal Rd Ste 100, Brookfield, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508384280 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | 10456 (Tennessee) | Secondary |
| 225100000X | Physical Therapist | 12517 (Connecticut) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ivyrehab Connecticut Inc | 8325203649 | 49 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston, in collaboration with The University of Texas Health Science Center at Houston (UTHealth), Baylor College of Medicine and the Georgia Regents University, report for the first time that the cholesterol-lowering drug simvastatin inhibits the growth of human uterine fibroid tumors.
A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.
Disrupting a metabolic pathway in the liver in a way that creates a more "cancer-like" metabolism actually reduces tumor formation in a mouse model of liver cancer.
The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).
Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.
› Verified 4 days ago
| Entity Name | Ivyrehab Connecticut Inc |
|---|---|
| Entity Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Entity Identifiers | NPI Number: 1265799365 PECOS PAC ID: 8325203649 Enrollment ID: O20120711000223 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston, in collaboration with The University of Texas Health Science Center at Houston (UTHealth), Baylor College of Medicine and the Georgia Regents University, report for the first time that the cholesterol-lowering drug simvastatin inhibits the growth of human uterine fibroid tumors.
A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.
Disrupting a metabolic pathway in the liver in a way that creates a more "cancer-like" metabolism actually reduces tumor formation in a mouse model of liver cancer.
The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).
Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Elizabeth C Roy, DPT 1377 Motor Pkwy Ste 307, Islandia, NY 11749-5258 Ph: (631) 580-5200 | Elizabeth C Roy, DPT 3 Federal Rd Ste 100, Brookfield, CT 06804 Ph: (203) 456-1010 |
News Archive
Researchers at the University of Texas Medical Branch at Galveston, in collaboration with The University of Texas Health Science Center at Houston (UTHealth), Baylor College of Medicine and the Georgia Regents University, report for the first time that the cholesterol-lowering drug simvastatin inhibits the growth of human uterine fibroid tumors.
A major international study involving a Simon Fraser University scientist has found that sequence differences in a gene crucial to the maintenance of our chromosomes' integrity predispose us to certain cancers.
Disrupting a metabolic pathway in the liver in a way that creates a more "cancer-like" metabolism actually reduces tumor formation in a mouse model of liver cancer.
The Hill's Healthwatch Blog: "Senate Democrats say an error in the food-safety bill passed Tuesday can be resolved in time to send the legislation to President Obama by the end of the year. Two senior leadership aides confirmed that the bill the Senate approved, 73-25, inadvertently contained tax provisions that, under the Constitution, must originate in the House of Representatives. That means the bill must be passed a second time by the Senate, giving critics such as Sen. Tom Coburn (R-Okla.) another chance to block it" (Rushing and Lillis, 12/1).
Metabolomx, a diagnostic company focused on breath analysis for the detection of cancer, today announced the Company was awarded a Small Business Innovation Research (SBIR) contract by the National Cancer Institute (NCI). The $1.14 million combined Phase I/II Fast-Track contract will support the research and development of Metabolomx' sensor array system to detect lung cancer.
› Verified 4 days ago